Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quintin Pan

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Molecular Cancer Research : MCR|October 29, 2009
RhoC expression and head and neck cancer metastasisMozaffarul Islam, Giant Lin, John C Brenner, et al.
Cancer Research|September 17, 2005
Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapyQuintin Pan, Li Wei Bao, Celina G Kleer, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2009
Inhibition of ErbB2(Her2) expression with small molecule transcription factor mimicsLori W Lee, Christopher E C Taylor, Jean-Paul Desaulniers, et al.
Investigational New Drugs|August 21, 2008
A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancerElaina M Gartner, Kent A Griffith, Quintin Pan, et al.
Frontiers in Oncology|November 24, 2016
Multiparameter Evaluation of the Heterogeneity of Circulating Tumor Cells Using Integrated RNA <i>In Situ</i> Hybridization and Immunocytochemical AnalysisYongqi Wu, Kyoung-Joo Jenny Park, Clayton Deighan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Phase II trial of tetrathiomolybdate in patients with advanced kidney cancerBruce G Redman, Peg Esper, Quintin Pan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2021
Multi-scale Pan-cancer Integrative Analyses Identify the STAT3-VSIR Axis as a Key Immunosuppressive Mechanism in Head and Neck CancerRamachandra Katabathula, Peronne Joseph, Salendra Singh, et al.
American Journal of Otolaryngology|May 24, 2022
The impact of microscopic versus macroscopic extranodal extension in oral cavity squamous cell carcinoma: National cancer database analysis and review of the literatureBrooke A Quinton, Claudia I Cabrera, Akina Tamaki, et al.
Frontiers in Oncology|December 12, 2024
Derivation of a comprehensive semi-empirical proton RBE model from published experimental cell survival data collected in the PIDE databaseJian-Yue Jin, Jiankui Yuan, Xiaohang Qin, et al.
Cancer Research|July 2, 2009
Preclinical development of a bifunctional cancer cell homing, PKCepsilon inhibitory peptide for the treatment of head and neck cancerLiwei Bao, Michael A Gorin, Manchao Zhang, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Molecular Cancer Research : MCR|October 29, 2009
RhoC expression and head and neck cancer metastasisMozaffarul Islam, Giant Lin, John C Brenner, et al.
Cancer Research|September 17, 2005
Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapyQuintin Pan, Li Wei Bao, Celina G Kleer, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2009
Inhibition of ErbB2(Her2) expression with small molecule transcription factor mimicsLori W Lee, Christopher E C Taylor, Jean-Paul Desaulniers, et al.
Investigational New Drugs|August 21, 2008
A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancerElaina M Gartner, Kent A Griffith, Quintin Pan, et al.
Frontiers in Oncology|November 24, 2016
Multiparameter Evaluation of the Heterogeneity of Circulating Tumor Cells Using Integrated RNA <i>In Situ</i> Hybridization and Immunocytochemical AnalysisYongqi Wu, Kyoung-Joo Jenny Park, Clayton Deighan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Phase II trial of tetrathiomolybdate in patients with advanced kidney cancerBruce G Redman, Peg Esper, Quintin Pan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2021
Multi-scale Pan-cancer Integrative Analyses Identify the STAT3-VSIR Axis as a Key Immunosuppressive Mechanism in Head and Neck CancerRamachandra Katabathula, Peronne Joseph, Salendra Singh, et al.
American Journal of Otolaryngology|May 24, 2022
The impact of microscopic versus macroscopic extranodal extension in oral cavity squamous cell carcinoma: National cancer database analysis and review of the literatureBrooke A Quinton, Claudia I Cabrera, Akina Tamaki, et al.
Frontiers in Oncology|December 12, 2024
Derivation of a comprehensive semi-empirical proton RBE model from published experimental cell survival data collected in the PIDE databaseJian-Yue Jin, Jiankui Yuan, Xiaohang Qin, et al.
Cancer Research|July 2, 2009
Preclinical development of a bifunctional cancer cell homing, PKCepsilon inhibitory peptide for the treatment of head and neck cancerLiwei Bao, Michael A Gorin, Manchao Zhang, et al.
Pageof 8